Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.3B | 1.3B | 1.2B |
Cost of revenue | 991M | 1.0B | 983M | 956M |
Gross profit | 346M | 333M | 322M | 286M |
Operating expense | ||||
Research & development | 84M | 93M | 89M | 87M |
Selling general and admin | 212M | 208M | 199M | 190M |
Other operating expenses | — | — | — | — |
Operating income | 50M | 32M | 34M | 9M |
Non operating interest income | ||||
Income | — | 12M | 9M | 10M |
Expense | — | — | — | — |
Other income expense | -4M | -12M | 14M | -5M |
Pretax income | 58M | 32M | 57M | 14M |
Tax provision | 2M | 0 | 1M | 0 |
Net income | 56M | 32M | 56M | 14M |
Basic EPS | 0.1 | 0.1 | 0.1 | 0.0 |
Diluted EPS | 0.1 | 0.1 | 0.1 | 0.0 |
Basic average shares | 575M | 569M | 563M | 556M |
Diluted average shares | 603M | 600M | 590M | 587M |
EBITDA | 73M | 55M | 47M | 26M |
Net income from continuing op. | 56M | 32M | 56M | 14M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |